Abnormal expression of insulin-like growth factor-I receptor in hepatoma tissue and its inhibition to promote apoptosis of tumor cells

Differential Roles of Insulin-like Growth Factor Receptor- and Insulin Receptor-mediated Signaling in the Phenotypes of Hepatocellular Carcinoma Cells

(2015) Ya-Wen Chen et al.   NEOPLASIA

Proton therapy for hepatocellular carcinoma

(2013) Ted C. Ling et al.   Chinese Journal of Cancer Research

New progress of non-surgical treatments for hepatocellular carcinoma

(2013) Ji-Wen Cheng et al.   MEDICAL ONCOLOGY

Hypovascular Nodules in Patients with Chronic Liver Disease: Risk Factors for Development of Hypervascular Hepatocellular Carcinoma

(2013) Tomoko Hyodo et al.   RADIOLOGY

Distinction immune genes of hepatitis-induced heptatocellular carcinoma

(2012) J. Hu et al.   BIOINFORMATICS

Mammary tumors that become independent of the type I insulin-like growth factor receptor express elevated levels of platelet-derived growth factor receptors

(2012) Craig I Campbell et al.   BMC CANCER

Inhibition of autocrine IGF-II on effect of human HepG2 cell proliferation and angiogenesis factor expression

(2012) Ninghua Yao et al.   TUMOR BIOLOGY

Expression of insulin-like growth factor-II, matrix metalloproteinases, and their tissue inhibitors as predictive markers in the peripheral blood of HCC patients

(2011) H.M. El Tayebi et al.   BIOMARKERS

A hepatoprotective Lindera obtusiloba extract suppresses growth and attenuates insulin like growth factor-1 receptor signaling and NF-kappaB activity in human liver cancer cell lines

(2011) Christian Freise et al.   BMC Complementary and Alternative Medicine

Epithelial-Mesenchymal Transition Predicts Sensitivity to the Dual IGF-1R/IR Inhibitor OSI-906 in Hepatocellular Carcinoma Cell Lines

(2011) H. Zhao et al.   MOLECULAR CANCER THERAPEUTICS

Upregulation of the Insulin Receptor and Type I Insulin-Like Growth Factor Receptor Are Early Events in Hepatocarcinogenesis

(2011) Eiman Aleem et al.   TOXICOLOGIC PATHOLOGY

Characteristics of Hepatic IGF-II Expression and Monitored Levels of Circulating IGF-II mRNA in Metastasis of Hepatocellular Carcinoma

(2010) Jing Qian et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Relationship of Insulin-Like Growth Factors System Gene Polymorphisms with the Susceptibility and Pathological Development of Hepatocellular Carcinoma

(2010) Chia-Jui Weng et al.   ANNALS OF SURGICAL ONCOLOGY

IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage

(2010) Victoria Tovar et al.   JOURNAL OF HEPATOLOGY

Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines

(2009) Z. Duan et al.   MOLECULAR CANCER THERAPEUTICS

Aflatoxin B1 modulates the insulin-like growth factor-2 dependent signaling axis

(2009) Tsuneyuki Ubagai et al.   TOXICOLOGY IN VITRO

Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway

(2008) Wei Cheng et al.   CARCINOGENESIS

Autocrine insulin-like growth factor-II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis

(2008) Tanja Nussbaum et al.   HEPATOLOGY

Molecular mechanisms of hepatocellular carcinoma

(2008) Rajagopal N. Aravalli et al.   HEPATOLOGY

Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma

(2008) Kai Breuhahn   WORLD JOURNAL OF GASTROENTEROLOGY